DelistingJul 24, 2026, 04:13 PM
VivoSim Labs Addresses Nasdaq Delisting Notice, Regains Compliance
AI Summary
VivoSim Labs, Inc. received a notice from Nasdaq on July 20, 2026, indicating non-compliance with the minimum $2.5 million stockholders' equity requirement, as its March 31, 2026, Form 10-K reported $(1,099,000). The company has 45 days to submit a plan to regain compliance. However, VivoSim Labs has since completed several transactions, including a $5.0 million milestone payment from Eli Lilly, a $4.0 million private placement, and warrant exercises totaling $5.1 million, which have brought its stockholders' equity above the $2.5 million threshold.
Key Highlights
- VivoSim Labs received a Nasdaq notice on July 20, 2026, for not meeting the $2.5 million stockholders' equity requirement.
- The company reported stockholders' equity of $(1,099,000) as of March 31, 2026.
- VivoSim Labs has 45 days (until September 3, 2026) to submit a plan to regain compliance.
- The company received a $5.0 million milestone payment from Eli Lilly in July 2026.
- A private placement closed on July 17, 2026, generating approximately $4.0 million in gross proceeds.
- Exercise of 3,370,827 common warrants increased stockholders' equity by approximately $5.1 million.
- As a result of these transactions, the company's stockholders' equity now exceeds $2.5 million.
Price Impact
More from VIVS